AAAAAA
Results:
1-12
|
Results: 12
Authors:
Maio, M
Altomonte, M
Calabro, L
Fonsatti, E
Citation: M. Maio et al., Bioimmunotherapeutic targets on angiogenetic blood vessels in solid malignangies, FRONT BIOSC, 6, 2001, pp. D776-D784
Authors:
Fonsatti, E
Del Vecchio, L
Altomonte, M
Sigalotti, L
Nicotra, MR
Coral, S
Natali, PG
Maio, M
Citation: E. Fonsatti et al., Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies, J CELL PHYS, 188(1), 2001, pp. 1-7
Authors:
Gasparollo, A
Coral, S
Ciullo, M
Prisco, A
Cattarossi, I
Sigalotti, L
Altomonte, M
Guardiola, J
Maio, M
Citation: A. Gasparollo et al., Unbalanced expression of HLA-A and -B antigens: A specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-gamma, INT J CANC, 91(4), 2001, pp. 500-507
Authors:
Fonsatti, E
Jekunen, AP
Kairemo, KJA
Coral, S
Snellman, M
Nicotra, MR
Natali, PG
Altomonte, M
Maio, M
Citation: E. Fonsatti et al., Endoglin is a suitable target for efficient imaging of solid tumors: In vivo evidence in a canine mammary carcinoma model, CLIN CANC R, 6(5), 2000, pp. 2037-2043
Authors:
Arienti, F
Belli, F
Napolitano, F
Sule-Suso, J
Mazzocchi, A
Gallino, GF
Cattelan, A
Santantonio, C
Rivoltini, L
Melani, C
Colombo, MP
Cascinelli, N
Maio, M
Parmiani, G
Citation: F. Arienti et al., Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells (vol 10, pg 2907, 1999), HUM GENE TH, 11(6), 2000, pp. 981-981
Authors:
Coral, S
Fonsatti, E
Sigalotti, L
De Nardo, C
Visintin, A
Nardi, G
Colizzi, F
Colombo, MP
Romano, G
Altomonte, M
Maio, M
Citation: S. Coral et al., Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complement, J CELL PHYS, 185(3), 2000, pp. 317-323
Authors:
Frumento, G
Franchello, S
Palmisano, GL
Nicotra, MR
Giacomini, P
Loke, YW
Geraghty, DE
Maio, M
Manzo, C
Natali, PG
Ferrara, GB
Citation: G. Frumento et al., Melanomas and melanoma cell lines do not express HLA-G, and the expressioncannot be induced by gamma IFN treatment, TISSUE ANTI, 56(1), 2000, pp. 30-37
Authors:
Coral, S
Sigalotti, L
Gasparollo, A
Cattarossi, I
Visintin, A
Cattelan, A
Altomonte, M
Maio, M
Citation: S. Coral et al., Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2 '-deoxycytidine (5-AZA-CdR), J IMMUNOTH, 22(1), 1999, pp. 16-24
Authors:
Arienti, F
Belli, F
Napolitano, F
Sule-Suso, J
Mazzocchi, A
Gallino, GF
Cattelan, A
Sanantonio, C
Rivoltini, L
Melani, C
Colombo, MP
Cascinelli, N
Maio, M
Parmiani, G
Citation: F. Arienti et al., Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells, HUM GENE TH, 10(18), 1999, pp. 2907-2916
Authors:
Fonsatti, E
Lamaj, E
Coral, S
Sigalotti, L
Nardi, G
Gasparollo, A
Colombo, MP
Altomonte, M
Maio, M
Citation: E. Fonsatti et al., In vitro analysis of the melanoma endothelium interaction increasing the release of soluble intercellular adhesion molecule 1 by endothelial cells, CANCER IMMU, 48(2-3), 1999, pp. 132-138
Authors:
Altomonte, M
Fonsatti, E
Lamaj, E
Cattarossi, I
Cattelan, A
Maio, M
Citation: M. Altomonte et al., Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1)in early breast cancer and benign breast lesions, BREAST CANC, 58(1), 1999, pp. 19-23
Authors:
Altomonte, M
Pucillo, C
Maio, M
Citation: M. Altomonte et al., The overlooked "nonclassical" functions of major histocompatibility complex (MHC) class II antigens in immune and nonimmune cells, J CELL PHYS, 179(3), 1999, pp. 251-256
Risultati:
1-12
|